Lisa Walters-Hoffert - Aug 19, 2024 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Director
Signature
/s/ Melissa Tosca, Attorney-in-Fact
Stock symbol
KPRX
Transactions as of
Aug 19, 2024
Transactions value $
$4,825
Form type
4
Date filed
8/20/2024, 01:00 PM
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Purchase $4.83K +1.25K $3.86 1.25K Aug 19, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple transactions at prices ranging from $3.815 to $3.8798. The reported price of $3.86 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.